
Shares of Radian Group Inc. RDN closed at $36.32 on July 2, near its 52-week high of $37.86. This proximity underscores investor confidence. It has the ingredients for further price appreciation. The stock is trading above the 50-day and 200-day simple moving averages (SMA) of $33.94 and $33.48, respectively, indicating solid upward momentum. SMA is a widely used technical analysis tool to predict future price trends by analyzing historical price data.
With a capitalization of $4.87 billion, the average number of shares traded in the last three months was 1.4 million.
Image Source: Zacks Investment Research
RDN is an Outperformer
Shares of Radian Group have gained 14.5% year to date, outperforming its industry and the Finance sector and the Zacks S&P 500 composite’s growth of 7.7% 8.9% and 4.8%, respectively.
Image Source: Zacks Investment Research
RDN has outperformed its peers, Old Republic International Corporation ORI, which has gained 3.7% year to date, while MetLife, Inc. MET and Assurant, Inc. AIZ have lost 2.1% and 10%, respectively.
RDN Shares are Affordable
Radian Group shares are trading at a forward price-to-book value of 1.12X, lower than the industry average of 2.73X, the Finance sector’s 4.27X and the Zacks S&P 500 Composite’s 8.33X. Its pricing, at a discount to the industry average, gives a better entry point to investors.
Image Source: Zacks Investment Research
RDN’s Encouraging Growth Projections
The Zacks Consensus Estimate for Radian Group’s 2025 revenues is pegged at $1.26 billion, implying a year-over-year improvement of 0.9%. The consensus estimate for 2026 earnings per share and revenues indicates an increase of 3% and 3.2%, respectively, from the corresponding 2025 estimates.
Radian Group has a solid surprise history. The multi-line insurer has a solid track record of beating earnings estimates in each of the last four quarters, the average being 12.45%.
Optimistic Analyst Sentiment on RDN
One of the two analysts covering the stock has raised estimates for 2025 and 2026 over the past 60 days. Thus, the Zacks Consensus Estimate for 2025 and 2026 moved 1.06% and 1.3% north, respectively, in the last 60 days.
Average Target Price for RDN Suggests Upside
Based on short-term price targets offered by six analysts, the Zacks average price target is $36.83 per share. The average suggests a potential 0.74% upside from the last closing price.
Image Source: Zacks Investment Research
Key Points to Note for RDN
Radian Group’s heightened focus on the core business and services with higher growth potential ensures a predictable and recurring fee-based revenue stream.
New business, combined with increasing annual persistency, should drive continued growth of the insurance-in-force portfolio. Radian Group’s mortgage insurance portfolio creates a strong foundation for future earnings. RDN has been witnessing a declining pattern of claim filings. We expect paid claims to decline further, thus strengthening the balance sheet and improving its financial profile.
This mortgage insurer has been strengthening its capital position with capital contributions, reinsurance transactions and cash position. This helps Radian Group engage in wealth distribution via dividend hikes and share buybacks.
Conclusion
Based on recent industry forecasts, Radian Group expects the private mortgage insurance market in 2025 to be approximately $300 billion, in line with recent years. Improving mortgage insurance portfolio, declining claims, a solid capital position and effective capital deployment should continue to favor mortgage insurers over the long term.
The 4.1% increase in quarterly dividend in the first quarter of 2025 marks the sixth consecutive year. RDN has increased the quarterly dividend, which has more than doubled over the past five years. Its current dividend yield of 2.8% betters the industry average of 2.5%, making it an attractive pick for yield-seeking investors.
Its solid growth projections as well as attractive valuations are other positives. Coupled with optimistic analyst sentiment and favorable ROIC, the time appears right for potential investors to bet on this Zacks Rank #2 (Buy) insurer. You can see the complete list of today’s Zacks #1 Rank stocks here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
MetLife, Inc. (MET) : Free Stock Analysis Report
Assurant, Inc. (AIZ) : Free Stock Analysis Report
Radian Group Inc. (RDN) : Free Stock Analysis Report
Old Republic International Corporation (ORI) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research